OSTN (115-133)



OSTN (115-133)

R1RR1F2FF2G3GG3I4II4P5PP5M6MM6D7DD7R8RR8I9II9G10GG10R11RR11N12NN12R13RR13L14LL14S15SS15N16NN16S17SS17R18RR18G19GG19

SMILES None
InChIKey LBPSGCKOVGOHBM-ZGLUUWDISA-N
Sequence RFGIPMDRIGRNRLSNSRG

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

OSTN (115-133)

R1RR1F2FF2G3GG3I4II4P5PP5M6MM6D7DD7R8RR8I9II9G10GG10R11RR11N12NN12R13RR13L14LL14S15SS15N16NN16S17SS17R18RR18G19GG19

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.